CO212 The Potential Long-Term Comparative Effectiveness of Larotrectinib Vs. Immune Checkpoint Inhibitors for Treatment of Metastatic NTRKGene Fusion-Positive Cancers
Jun 1, 2023, 00:00
10.1016/j.jval.2023.03.2437
https://www.valueinhealthjournal.com/article/S1098-3015(23)02627-X/fulltext
Title :
CO212 The Potential Long-Term Comparative Effectiveness of Larotrectinib Vs. Immune Checkpoint Inhibitors for Treatment of Metastatic NTRKGene Fusion-Positive Cancers
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(23)02627-X&doi=10.1016/j.jval.2023.03.2437
First page :
Section Title :
Open access? :
No
Section Order :
11675